Target intelligence / Profile preview

Glutamate oxaloacetate transaminase 2 (GOT2) (FABPpm)

Target
FABPpm
Molecular classification
Transporter, Enzyme, Aminotransferase
01

Overview

Plasma membrane fatty acid-binding protein (FABPpm) is a 43-kDa peripheral membrane protein that is identical to the mitochondrial isoform of aspartate aminotransferase (mAST), encoded by the GOT2 gene (UniProt P00505). While its primary enzymatic role occurs within the mitochondria as part of the malate-aspartate shuttle, it is also localized to the plasma membrane where it functions as a transporter for long-chain fatty acids (LCFAs) (Glatz et al., 2010). FABPpm facilitates the initial binding and translocation of fatty acids across the lipid bilayer, often working in coordination with other transporters like CD36 to regulate lipid flux (Bonen et al., 2004). In metabolic disorders such as obesity and type 2 diabetes, FABPpm expression and its translocation to the cell surface are often increased in skeletal muscle and liver, leading to enhanced fatty acid uptake and contributing to lipotoxicity and insulin resistance (Chabowski et al., 2007). Because of its role in lipid oversupply, it is considered a potential therapeutic target for metabolic syndrome, although its dual role in essential mitochondrial metabolism poses a significant challenge for drug specificity. Experimental inhibitors like sulfo-N-succinimidyl oleate (SSO) have demonstrated that blocking FABPpm can significantly reduce LCFA uptake in various tissues, providing a proof-of-concept for metabolic intervention (Luiken et al., 1999).

Other names
Plasma membrane fatty acid-binding proteinMitochondrial aspartate aminotransferasemASTAspartate aminotransferase 2Fatty acid-binding protein, plasma membrane-associated
02

Mechanism of action

Inhibition of long-chain fatty acid (LCFA) uptake across the plasma membrane (Luiken et al., 1999)

03

Biological functions

Long-chain fatty acid transport (Glatz et al., 2010)Amino acid metabolismMalate-aspartate shuttle (mitochondrial function)Fatty acid uptake and signaling
04

Disease associations

Obesity (Bonen et al., 2004)Type 2 diabetesInsulin resistance (Chabowski et al., 2007)Non-alcoholic fatty liver disease (NAFLD)Cardiovascular disease
05

Safety considerations

Disruption of the mitochondrial malate-aspartate shuttle (essential for NADH transport)Impairment of systemic amino acid metabolismPotential for cardiac or hepatic toxicity due to mitochondrial dysfunctionOff-target effects on intracellular aspartate aminotransferase activity
06

Interacting drugs

Sulfo-N-succinimidyl oleate (SSO)
07

Biomarkers

FABPpm protein expression levels in skeletal muscle or liver biopsies (Bonen et al., 2004)Plasma long-chain fatty acid (LCFA) clearance ratesIntracellular lipid accumulation (triacylglycerol content)

Beyond the preview

Go deeper on Glutamate oxaloacetate transaminase 2 (GOT2) (FABPpm).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glutamate oxaloacetate transaminase 2 (GOT2) (FABPpm).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call